Trial Profile

A Phase 1a clinical study of REVTx-100 in combination with REVTx-300

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 06 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Feb 2024 According to a Revelation Biosciences media release, gross proceeds to the Company from the offering are approximately $6.2 million, intends to use the net proceeds to further the development of this phase1a combination study.
22 May 2023 According to a Revelation Biosciences media release, the company expect to initiate this study in Q4 of this year.
30 Mar 2023 According to a Revelation Biosciences media release, this study is expected to be initiated in the second half of 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com